Alpha Wave Global, LP Amylyx Pharmaceuticals, Inc. Transaction History

Alpha Wave Global, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.07 - $18.46 $84,755 - $129,626	-7,022 Reduced 0.82%	846,240 $12.5 Million
Q2 2023 Aug 14, 2023	SELL	$20.98 - $31.42 $1.62 Million - $2.42 Million	-77,075 Reduced 8.28%	853,262 $18.4 Million
Q1 2023 May 15, 2023	BUY	$27.71 - $40.93 $3.02 Million - $4.47 Million	109,117 Added 13.29%	930,337 $27.3 Million
Q4 2022 Feb 14, 2023	BUY	$29.75 - $39.26 $3.59 Million - $4.73 Million	120,585 Added 17.21%	821,220 $30.3 Million
Q2 2022 Aug 12, 2022	BUY	$6.85 - $19.93 $571,392 - $1.66 Million	83,415 Added 13.51%	700,635 $13.5 Million
Q1 2022 May 13, 2022	BUY	$12.85 - $32.9 $7.93 Million - $20.3 Million	617,220 New	617,220 $7.93 Million

139

46.5M

226K

909K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Alpha Wave Global, LP, based on Form 13F filings with the SEC.

Stay updated on Alpha Wave Global, LP with notifications on news.